Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. RIO-North America: a randomized controlled trial

✍ Scribed by Constans, J.

• Book ID: 123120052
• Publisher: Masson Editeur
• Year: 2006
• Tongue: French
• Weight: 63 KB
• Volume: 31
• Category: Article
• ISSN: 0398-0499
• DOI: 10.1016/S0398-0499(06)76549-0